Sorafenib in Combination With Capecitabine: An Oral Regimen for Patients With HER2-Negative Locally Advanced or Metastatic Breast Cancer

✍ Scribed by Baselga, J.; Segalla, J. G. M.; Roche, H.; del Giglio, A.; Pinczowski, H.; Ciruelos, E. M.; Filho, S. C.; Gomez, P.; Van Eyll, B.; Bermejo, B.; Llombart, A.; Garicochea, B.; Duran, M. A. C.; Hoff, P. M. G.; Espie, M.; de Moraes, A. A. J. G.; Ribeiro, R. A.; Mathias, C.; Gil Gil, M.; Ojeda, B.; Morales, J.; Kwon Ro, S.; Li, S.; Costa, F.

• Book ID: 125853341
• Publisher: American Society of Clinical Oncology
• Year: 2012
• Tongue: English
• Weight: 177 KB
• Volume: 30
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2011.36.7771